Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffen Weikert

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Fertility and Sterility|April 16, 2005
Expression levels of the inhibitor of apoptosis survivin in testes of patients with normal spermatogenesis and spermatogenic failureSteffen Weikert, Mark Schrader, Markus Müller, et al.
International Journal of Cancer|March 12, 2005
Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosisSteffen Weikert, Frank Christoph, Mark Schrader, et al.
Cancer Letters|May 18, 2005
The inhibitor of apoptosis (IAP) survivin is expressed in human testicular germ cell tumors and normal testesSteffen Weikert, Mark Schrader, Hans Krause, et al.
Advances in Therapy|November 4, 2019
Is the Recommendation of a Pelvic Lymphadenectomy in Conjunction with Radical Prostatectomy in Prostate Cancer Patients Justified? Report from a Multidisciplinary Expert Panel MeetingAlexander Winter, Rolf Harzmann, Johann Jakob Wendler, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2012
Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinomaChristoph Seidel, Jonas Busch, Steffen Weikert, et al.
International Journal of Molecular Medicine|July 14, 2005
Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomasSteffen Weikert, Frank Christoph, Jens Köllermann, et al.
International Journal of Andrology|July 29, 2005
Quantification of survivin mRNA in testes of infertile patients and in testicular germ cell tumours: high levels of expression associated with normal spermatogenesisSteffen Weikert, Mark Schrader, Frank Christoph, et al.
International Journal of Cancer|April 28, 2006
Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladderFrank Christoph, Steffen Weikert, Carsten Kempkensteffen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatmentJens Köllermann, Steffen Weikert, Martin Schostak, et al.
BMC Urology|October 26, 2019
Ureteroenteric strictures: a single center experience comparing Bricker versus Wallace ureteroileal anastomosis in patients after urinary diversion for bladder cancerFrank Christoph, Franziska Herrmann, Peter Werthemann, et al.
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Fertility and Sterility|April 16, 2005
Expression levels of the inhibitor of apoptosis survivin in testes of patients with normal spermatogenesis and spermatogenic failureSteffen Weikert, Mark Schrader, Markus Müller, et al.
International Journal of Cancer|March 12, 2005
Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosisSteffen Weikert, Frank Christoph, Mark Schrader, et al.
Cancer Letters|May 18, 2005
The inhibitor of apoptosis (IAP) survivin is expressed in human testicular germ cell tumors and normal testesSteffen Weikert, Mark Schrader, Hans Krause, et al.
Advances in Therapy|November 4, 2019
Is the Recommendation of a Pelvic Lymphadenectomy in Conjunction with Radical Prostatectomy in Prostate Cancer Patients Justified? Report from a Multidisciplinary Expert Panel MeetingAlexander Winter, Rolf Harzmann, Johann Jakob Wendler, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2012
Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinomaChristoph Seidel, Jonas Busch, Steffen Weikert, et al.
International Journal of Molecular Medicine|July 14, 2005
Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomasSteffen Weikert, Frank Christoph, Jens Köllermann, et al.
International Journal of Andrology|July 29, 2005
Quantification of survivin mRNA in testes of infertile patients and in testicular germ cell tumours: high levels of expression associated with normal spermatogenesisSteffen Weikert, Mark Schrader, Frank Christoph, et al.
International Journal of Cancer|April 28, 2006
Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladderFrank Christoph, Steffen Weikert, Carsten Kempkensteffen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatmentJens Köllermann, Steffen Weikert, Martin Schostak, et al.
BMC Urology|October 26, 2019
Ureteroenteric strictures: a single center experience comparing Bricker versus Wallace ureteroileal anastomosis in patients after urinary diversion for bladder cancerFrank Christoph, Franziska Herrmann, Peter Werthemann, et al.
Pageof 10